Trexquant Investment LP Purchases Shares of 41,357 Waters Co. (NYSE:WAT)

Trexquant Investment LP acquired a new position in shares of Waters Co. (NYSE:WAT) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 41,357 shares of the medical instruments supplier’s stock, valued at approximately $15,343,000. Trexquant Investment LP owned approximately 0.07% of Waters at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Bank of Jackson Hole Trust acquired a new stake in Waters during the fourth quarter worth $34,000. Fortitude Family Office LLC boosted its position in shares of Waters by 235.7% during the 4th quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock valued at $35,000 after acquiring an additional 66 shares in the last quarter. Steward Partners Investment Advisory LLC increased its stake in Waters by 129.3% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier’s stock valued at $35,000 after acquiring an additional 53 shares during the period. Murphy & Mullick Capital Management Corp acquired a new position in Waters in the fourth quarter worth about $42,000. Finally, EverSource Wealth Advisors LLC lifted its stake in Waters by 54.3% during the fourth quarter. EverSource Wealth Advisors LLC now owns 125 shares of the medical instruments supplier’s stock worth $46,000 after purchasing an additional 44 shares during the period. 94.01% of the stock is currently owned by institutional investors.

Waters Price Performance

Waters stock opened at $355.43 on Wednesday. The stock has a market cap of $21.12 billion, a price-to-earnings ratio of 33.19, a P/E/G ratio of 3.79 and a beta of 1.00. Waters Co. has a 12-month low of $279.24 and a 12-month high of $423.56. The company has a quick ratio of 0.65, a current ratio of 0.94 and a debt-to-equity ratio of 1.14. The business’s 50-day simple moving average is $385.54 and its 200 day simple moving average is $373.45.

Waters (NYSE:WAT) last released its earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 EPS for the quarter, topping analysts’ consensus estimates of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%. As a group, research analysts anticipate that Waters Co. will post 12.86 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on WAT shares. JPMorgan Chase & Co. increased their target price on Waters from $380.00 to $390.00 and gave the stock a “neutral” rating in a report on Thursday, March 6th. Baird R W upgraded Waters from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, March 26th. Robert W. Baird upgraded shares of Waters from a “neutral” rating to an “outperform” rating and boosted their target price for the company from $396.00 to $407.00 in a research note on Wednesday, March 26th. StockNews.com cut shares of Waters from a “buy” rating to a “hold” rating in a research report on Tuesday, February 25th. Finally, Wells Fargo & Company boosted their price target on shares of Waters from $415.00 to $420.00 and gave the company an “overweight” rating in a research report on Thursday, February 13th. Ten research analysts have rated the stock with a hold rating, seven have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $401.31.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.